PF-Atlas › Clinical Trials › NCT02603666
Elastography of the Liver in Cystic Fibrosis Patients. Diagnostic and Prognostic Aspects
Fibroscan · Not specified
Registry ID
NCT02603666
Phase
Not specified
Status
Completed
Drug / intervention
Fibroscan
Sponsor
Karolinska University Hospital
Start
2012-01
Enrollment
130
About this trial
The aim of the study is to find CF patients at risk for cystic fibrosis related liver disease (CFLD). Comparison of ultrasound by two modalities and biochemical markers with histological evaluation of liver biopsy if present.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT02603666 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.